LeaderVoices with Sadhna Bokhiria
How do you lead with clarity in systems built on complexity? In this episode of LeaderVoices [https://podcast.kiria.co/], Dr. Sadhna Bokhiria [https://sbokhiria.com/] welcomes Dr. Anupam Agarwal [https://www.linkedin.com/in/anupamagarwalmd/]—a physician executive, biotech investor, and board leader whose career bridges medicine, global pharma, and venture capital. With over 19 years in the pharmaceutical industry—across GSK, Pfizer, and Gilead—and more than a decade in academic and clinical practice, Anupam brings a rare, multidimensional lens to the future of healthcare. Now serving as the incoming president of the Harvard Club of San Francisco and a member of the Cardiovascular Science Research Consortium, he continues to shape the next era of science and strategy. This conversation unpacks: * The mindset shift from practicing medicine to leading in industry * How to navigate the ethical tensions of pharma leadership * Why cardiovascular innovation is at an inflection point * What biotech investors look for beyond the pitch deck * And how curiosity, humility, and systems thinking have shaped Anupam's journey Why This Episode Matters Whether you're in healthcare, leadership, or venture—this episode is a front-row seat to how science, business, and purpose can align. Anupam doesn't just talk about innovation—he's lived it. And his reflections offer a masterclass in how to lead when lives, ethics, and billion-dollar decisions are on the line. Top Takeaways * Clinical credibility matters in boardrooms. It earns trust and keeps the patient in the picture. * The best investors aren't just looking for IP—they're looking for mission clarity and people who can navigate ambiguity. * Ethical leadership in pharma means holding tension between innovation, access, and sustainability. * In cardiovascular science, we're on the brink of a new chapter—but it'll take public-private synergy to get there. Timestamps 00:00 – Welcome + Guest intro 04:15 – Leaving the clinic: why Anupam transitioned into industry 08:42 – GSK, Pfizer, Gilead: lessons in leadership from global pharma 14:20 – The ethics of speed and scale in drug development 21:30 – Cardiovascular breakthroughs and unmet needs 29:10 – What makes a biotech venture backable in 2025 35:40 – Advice to early-career physician leaders 41:12 – Closing reflections: staying grounded in curiosity Connect with Dr. Anupam Agarwal LinkedIn [https://www.linkedin.com/in/anupamagarwalmd/] 👉 Subscribe + leave us a review if this episode moved you. It helps more people discover the voices shaping tomorrow's leadership.
28 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af LeaderVoices with Sadhna Bokhiria-fællesskabet!